Probiotics China News Bites – August 2023

HPA-China Monthly Newsletter

  • Japan Bioscience Laboratory (JBSL) launched Biozyme, a high efficiency postbiotic, whose active substances include amino acids and peptides from decomposing enzymes, polysaccharides and oligosaccharides, organic acids, vitamins and minerals, etc. It is reported that this ingredient is produced by Bacillus biological enzyme fermentation process and is rich in physiologically active substances. Its extract contains at least 40 kinds of fermented vegetables and herbs, and the active ingredients can be decomposed into low-molecular compounds through the ripening process, so as to be more effectively absorbed in the body.
  • IFF opens an innovation center in North America, which can enhance the development capabilities of flavor and ingredient products, further increase food product design, and support the development of North American food. It is reported that the center has now become the company’s second largest innovation center in North America, with a total of ten laboratories and six pilot factories, which serve the dual goals of strengthening customer support and promoting new product development.
  • IFF’s functional ingredients portfolio business was down more than 20% in the second quarter ended June 30. IFF’s net income for the quarter was US$27 million, down 75% year-on-year in the second quarter of last year; net sales were US$2.93 billion, down 11% year-on-year in the second quarter of last year. Among them, Nourish department sales fell 14% in the quarter; health and biological sciences sales fell 22%.
  • Probiotical SpA announces that Stauber Performance Ingredients will become the North American distributor of its SkinBac brand. It is reported that SkinBac is the company’s multi-strain skin-targeted postbiotic series, made of a proprietary mild inactivation method that preserves microbial cell structure, allowing manufacturers to determine the exact content of finished products during the production process and shelf life.
  • Novozymes and Arla Foods Ingredients have reached a cooperation on the research and development of precision fermented protein ingredients, which will enable the two companies to further explore special medical nutrition solutions and expand to other fields in the future. According to Novozymes, precision fermentation is a technology to fine-tune the output of microbial molecules, which can control the fermentation process and achieve customized protein composition.
  • Recently, Arla Foods Ingredients signed a distribution agreement with Zhongbai Xingye Food Technology Co., Ltd. Arla will supply its products to the Chinese food and nutrition market. The new agreement focuses on three key areas: infant nutrition, functional nutrition and food and beverages.
  • DSM-Firmenich announced its first H1 results after the merger. According to the company, total sales in the first half of this year were 6.15 billion euros ($6.76 billion), down 5 percent from the first half of last year, due to headwinds faced by the animal nutrition and health (ANH) division, as well as weak vitamin market conditions. In addition to the financial figures, DSM Firmenich also stated that they are actively working to advance their strategic objectives and foster a sustainable, purpose-driven approach.
  • Austrianova and ProAgni built collaboration, which will develop and commercialize probiotics that can be used in shelf-stable probiotic additives for cattle feed and other farm animals.
  • Recently, Ausnutria’s nutrition brand, Aysen, has launched a series of new probiotic products specially designed for children, “Daily Nutrition”, to further improve its overall nutrition category layout. In addition, Aysen has previously launched a variety of products such as Ayisen “First Care” children’s probiotics, Ayisen Yuanli Lactoferrin, Ayisen Zhihu DHA, Ayisen Anmin probiotics, etc., to provide care for parents and children intestinal health, comprehensive nutritional supplementation, enhancing immunity, promoting eye and brain development, etc.
  • On the evening of August 24, JuneYao Health (605388) disclosed its 2023 semi-annual report. In the first half of this year, the company achieved operating income of 879 million yuan, a year-on-year increase of 109.94%; net profit attributable to the parent was 47.6772 million yuan, a year-on-year increase of 4.97%; The operating income of probiotic food was 70.0393 million yuan, a year-on-year increase of 221.02%.
  • Recently, the Yibeishi brand launched the Xiaolanyao probiotics. The new product specially adds the patented bacterium Slimram-1TM, namely Bifidobacterium lactis CECT8145, which not only helps to regulate the human immune system, but also regulates the intestinal flora to maintain a healthy microecology.
  • Recently, Wang Baobao’s new product “extra point”: kale powder solid drink was launched. It is reported that the new product is designed to help consumers more easily supplement vegetables. Each bar contains 65g/100g of dietary fiber, about 38 times that of spinach, and 30mg/100g of vitamin C, 10 times that of carrots. In addition, prebiotics are added, and no coloring, food flavor and white sugar are added.
  • On August 7, Ambrosial announced at the World Dairy Conference the launch of the industry’s first normal-temperature active probiotic yogurt. The new product adds 1 billion active probiotics (LGG), reduces sucrose, increases protein by 35%, and the net content of the new product is 205g/box.
  • On August 7, Beihai Ranch launched 7 kinds of probiotics golden pomelo-flavored fermented milk. The product uses 100% raw milk source, contains 7 kinds of probiotics, fresh pomelo and mellow yogurt, refreshing and relieves greasy.
  • On August 7th, Blueglass officially announced the launch of 8 new products in the Lightweight Waist series: five types of yogurts, No. 1, No. 2, No. 3, No. 4 and Buff 5, as well as the Light and Good State, the Burning Good State and A full Cup of Good Condition which of three types of yogurt snacks. According to reports, the five yogurts all contain Alpha small blue bottle oat molecular explosion bubbles, and each cup has 100 billion active probiotics.
  • Recently, XOXO, a British prebiotic soda start-up, announced that it has received 1.5 million pounds (about 13.66 million yuan) in financing. Several venture capital institutions jointly completed this investment, and the funds will be used to help XOXO accelerate team building and expand marketing channels in the UK, EU and more regions.
  • On the evening of August 1, Scitop Bio-tech (300858) disclosed its semi-annual report. In the first half of 2023, the company achieved operating income of 140 million yuan, a year-on-year decrease of 10.79%; net profit was 40.3326 million yuan, a year-on-year decrease of 10.01%. During the reporting period, the company’s edible probiotic product business income was 86.2528 million yuan, a year-on-year increase of 60.53%. The sales of edible probiotic products have surpassed compound food additives, and it has become the company’s largest proportion of revenue, the strongest profitability, and the most obvious market competitive advantage. Business segments.
  • Recently, the National Natural Science Foundation of China released the guidelines and application notes for the third batch of major projects of the National Natural Science Foundation of China during the 14th Five-Year Plan. Among them, in 2023, the Ministry of Life Sciences issued a total of 9 major project guidelines and plans to fund 6 major projects. The direct cost budget of the project application shall not exceed 15 million yuan per project. The major project in the field of food is “Biological Basis of Breeding of Excellent Food Probiotics”.
  • Recently, Leli launched a new M-16V probiotic, which provides solutions for people with allergies and comprehensively cares for sensitive constitutions. It is understood that Leli M-16V probiotics use Bifidobacterium breve M-16V, Lactobacillus rhamnosus HN001, Lactobacillus plantarum LP28 and other specific strains as the core strains and are produced in an independent allergen-free production plant to prevent cross-contamination with other foods.
  • On July 15, the Baoyuan Guangtong probiotic factory project led by probiotic series health products held a launching ceremony in Luquan District, Shijiazhuang City. It is reported that the Baoyuan Guangtong probiotics factory project is in Tongye Town, Luquan District. It is jointly constructed by Beijing Baoyuan Guangtong Technology Group and Hebei Qiquan Tourism Development Co., Ltd., covering an area of about 120 mu, with a total investment of about 300 million yuan. The project will focus on the construction of probiotic series product research and development and production bases, intestinal gene health management center, hyaluronic acid (sodium hyaluronate) production center, traditional Chinese medicine fermentation extraction product production center, etc., and will also build a special talent training base in Luquan District Carry out group layout.
  • According to 36 Kr’s report on July 21, Hefei Aiqu Tuou Technology Co., Ltd. has recently completed a seed round of financing of several million yuan, and the investor is Nanjing Xingcheng Health Management Co., Ltd. The funds raised in this round are mainly used for product development and marketing of the company’s brand “Chunfei Probiotics”. At the end of this year, the company will launch the next round of financing to further expand the R&D team and build a dealer network.

Sign Up to Receive China Updates Weekly Newsletter for FREE, HERE

Visit HPA-China’s Information Hub, HERE